Tumoral melanosis involving the sentinel lymph nodes: A case report
Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany.Journal of Cutaneous Pathology (Impact Factor: 1.58). 04/2007; 34(3):284-6. DOI: 10.1111/j.1600-0560.2006.00609.x
Tumoral or nodular melanosis is characterized by a clinical lesion suspicious for malignant melanoma, the histopathological correlate is a nodular accumulation of melanophages in the dermis. We present a patient with nodular melanosis involving also the sentinel lymph nodes and discuss possible differential diagnoses as well as prognostic and therapeutic implications.
Article: Prognostic models in melanoma[Show abstract] [Hide abstract]
ABSTRACT: Predicting which patients with primary melanoma are at risk of developing metastastic disease is important for making rational therapeutic decisions. Tumor thickness alone is the most commonly used predictor of survival, but other clinical and pathologic variables also play an important role. We have developed two multivariate logistic regression models to predict survival in patients who have primary melanoma. The first of these models assigns patients to two groups based on radial or vertical growth phase. The probability of survival for those patients with vertical growth phase tumors was further determined based on a model using six variables (mitotic rate, tumor infiltrating lymphocytes, tumor thickness, anatomic site of the primary tumor, sex, and histologic regression) that have the greatest strength as independent predictors of survival. This model is 89% accurate for predicting survival in patients with vertical growth phase tumors. A second model has been developed that uses readily available clinical parameters to predict survival. Four variables (tumor thickness, anatomic site, age, and sex) entered into the model as powerful independent predictors. Clinical algorithms for assessing patient risk are provided.Seminars in Oncology 03/1997; 24(1 Suppl 4):S2-7. · 3.90 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: The histological diagnosis of melanocytic lesions is probably one of the more difficult areas in histopathology because of the wide spectrum of melanocytic entities and all their subtle variations. Additionally, it is an area with significant medicolegal implications. While there is a vast literature in relation to melanocytic lesions, some histopathological features recognized through the personal experience of specialists are not described in the principal texts. This article reviews these lesser known features of the different categories of melanocytic lesion.Diagnostic Histopathology 01/2008; 14(1-14):1-10. DOI:10.1016/j.mpdhp.2007.11.005
- [Show abstract] [Hide abstract]
ABSTRACT: We present an extremely rare case of an orbital melanocytoma that occurred in a 51-year-old man. The patient suffered from diplopia and mild exophthalmos of the right eye for 2 months. Brain magnetic resonance imaging showed a well-demarcated round mass 3.5 cm in diameter in the right orbit. We performed total resection of this tumor. Histological findings revealed a proliferation of large polygonal cells with fine pigment granules in the cytoplasm and prominent nucleoli. Although these tumor cells revealed immunohistochemical reactivity in HMB-1, there was no S-100 or Melan A antibody reactivity. Also, there were no malignant findings of nuclear polymorphism, mitoses, or necrosis. The brown pigments were confirmed to be melanin by bleaching and the Fontana-Masson silver stain method. The MIB-1 labeling index was less than 1%. This tumor also consisted of 50% melanophages, which revealed immunohistochemical reactivity in CD68, CD163, and in (1-AT antibodies. These histological findings led us to diagnose an orbital melanocytoma with partial tumor regression.Brain Tumor Pathology 02/2009; 26(1):25-9. DOI:10.1007/s10014-008-0242-8 · 1.22 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.